Limited Use Note(s)

Government of Ontario Logo
CONJUGATED ESTROGENS0.625mg SR Tab
Reason For Use CodeClinical Criteria
398For short-term use in women who are experiencing symptoms of menopause. Note: Recent evidence has demonstrated that use of hormone replacement therapy (HRT) increases the rate of coronary events, breast cancer, dementia, stroke, venous thromboembolism and referrals for abnormal vaginal bleeding. These risks should be discussed with patients and reviewed periodically.
LU Authorization Period: 1 year